BioXcel Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. BioXcel Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 268% to $1,380,000. Profit margin reached -12975%. Total operating expenses were $171,902,000.
Profit Margin
| 2015 | 0 | -636K | |
|---|---|---|---|
| 2016 | 0 | -2.12M | |
| 2017 | 0 | -4.53M | |
| 2018 | 0 | -19.27M | |
| 2019 | 0 | -32.33M | |
| 2020 | 0 | -82.00M | |
| 2021 | 0 | -106.63M | |
| 2022 | 375K | -171.84M | -45826.4% |
| 2023 | 1.38M | -179.05M | -12974.86% |
BTAI Income Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 1.38M | 375K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 1.26M | 20K | 297K | 188K | 156K | 0 | 1K | 0 | 0 |
Gross profit | 120K | 355K | -297K | -188K | -156K | 0 | -1K | 0 | 0 |
Operating exp. | |||||||||
Research and development | 84.32M | 91.23M | 52.70M | 57.99M | 25.79M | 14.55M | 2.69M | 1.39M | 233K |
Selling and marketing | 19.89M | 13.00M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 171.90M | 160M | 106.93M | 82.29M | 33.60M | 19.96M | 4.53M | 2.12M | 636K |
Operating income | -171.78M | -159.64M | -106.93M | -82.29M | -33.60M | -19.96M | -4.53M | -2.12M | -636K |
Other income (expenses), net | -7.27M | -6.11M | 4K | 128K | 633K | 692K | -2K | 0 | 0 |
Income before tax | -179.05M | -165.75M | -106.93M | -82.16M | -32.96M | -19.27M | -4.53M | -2.12M | -636K |
Income tax expense | 0 | 6.09M | -301K | -161K | -633K | 692K | 0 | 0 | 0 |
Net income | -179.05M | -171.84M | -106.63M | -82.00M | -32.33M | -19.27M | -4.53M | -2.12M | -636K |
Earnings per share | |||||||||
Basic EPS | -6.15 | -6.13 | -4.04 | -3.78 | -1.99 | -1.32 | -0.3 | -0.14 | -0.03 |
Diluted EPS | -6.15 | -6.13 | -4.04 | -3.78 | -1.99 | -1.32 | -0.3 | -0.14 | -0.03 |
| Data source | Data source | Data source | Data source | Data source | Data source |